Jay Venkatesan - Dec 20, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: President and Chief Executive Officer and Director, Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Stock symbol: ELTX
Transactions as of: Dec 20, 2021
Transactions value $: $8,976
Form type: 4
Date filed: 12/22/2021, 03:06 PM
Previous filing: Dec 20, 2021
Next filing: Dec 29, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Purchase	$8.98K	+3.53K	+0.26%	$2.54	1.36M	Dec 20, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.52 to $2.55 inclusive.

Remarks:

President and Chief Executive Officer and Director